ERBB2 and cancer: Among postulated mechanisms for such a benefit are the inhibition of cancer cell growth and suppression of human epidermal growth factor receptor 2 overexpression and inhibition of mammalian target of rapamycin (mTOR).33–35 Metformin activates the AMP-activated protein kinase (AMPK) pathway, a major sensor of the energy status of cells.